Industry News
Pancreatic cancer risk linked to changes in mouth bacteria
4/20/2016
For the first time, a new study gives direct evidence that certain changes in the oral microbiome - the mix of bacteria in the mouth - could be a risk factor for pancreatic cancer.
Stem cell technique predicts patients likely to have severe chemo reaction
4/20/2016
Study shows heart cells generated from a patient's own skin-derived stem cells can predict if they are likely to suffer severe heart muscle damage from a common chemotherapy drug.
Aspirin use may help prevent bile duct cancer, Mayo-led study finds
4/20/2016
A team of current and former Mayo Clinic researchers has discovered that aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma.
UTSW surgeons develop innovative technique for reconstructing breast after mastectomy
4/20/2016
UT Southwestern Medical Center plastic surgeons have developed a new breast reconstruction technique that combines advantages of two different types of microsurgical procedures using abdominal and...
Breast cancer patients receiving Herceptin treatment should be monitored for heart damage at any age
4/20/2016
Breast cancer patients undergoing treatment with trastuzumab-containing regimens should be monitored for heart damage regardless of age, according to a new multi-centre study in Ontario.
Noninvasive test detected colorectal cancer in previously unscreened patients
4/19/2016
A noninvasive colorectal cancer screening test detected the disease in patients who had previously avoided more invasive screening measures, according to research presented at the AACR Annual...
Bristol-Myers Squibb has announced the first overall survival results from CheckMate -069, a Phase II trial evaluating the investigational combination of nivolumab and ipilimumab vs.
Phase III data for nivolumab in head and neck cancer show biggest increase in survival for 20 years
4/19/2016
Bristol-Myers Squibb has announced results from the pivotal CheckMate -141 Phase III clinical trial which showed that treatment with nivolumab, which is investigational in head and neck cancer...
New treatment for advanced melanoma shows promise
4/19/2016
In a study appearing in JAMA, Antoni Ribas, M.D., Ph.D., of the University of California-Los Angeles, and colleagues examined tumor response and overall survival following administration of the...
New HPV vaccine could curb cervical cancers and health costs if adopted widely
4/19/2016
A Yale-led study finds that a new vaccine for human papillomavirus (HPV) would significantly reduce both cervical cancer incidence and healthcare costs if states coordinated policies to improve...